Tyrosine phosphatase PTPRD suppresses colon cancer cell migration in coordination with CD44

Experimental and Therapeutic Medicine

Volumn 2, Issue 3, 2011, Pages 457-463

  Funato, Kosuke ^a   Yamazumi, Yusuke ^a   Oda, Takeaki ^a   Akiyama, Tetsu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

catenin TCF signaling; Cancer cell migration; CD44; Receptor type tyrosine protein phosphatase

Indexed keywords

BETA CATENIN; HERMES ANTIGEN; PROTEIN TYROSINE PHOSPHATASE; RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASE DELTA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER SURVIVAL; CELL ADHESION; CELL MIGRATION; COLON CANCER; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 79953284982     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.231     Document Type: Article

References (38)

1. Tiganis T and Bennett A: Protein tyrosine phosphatase function: the substrate perspective. Biochem J 402: 1-15, 2007.
2. Ensslen-Craig S and Brady-Kalnay S: Receptor protein tyrosine phosphatases regulate neural development and axon guidance. Dev Biol 275: 12-22, 2004.
3. Stepanek L, Stoker A, Stoeckli E and Bixby J: Receptor tyrosine phosphatases guide vertebrate motor axons during development. J Neurosci 25: 3813-3823, 2005.
4. Uetani N, Kato K, Ogura H, et al: Impaired learning with enhanced hippocampal long-term potentiation in PTPdeltadeficient mice. EMBO J 19: 2775-2785, 2000.
5. Sjöblom T, Jones S, Wood L, et al: The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274, 2006.
6. Weir B, Woo M, Getz G, et al: Characterizing the cancer genome in lung adenocarcinoma. Nature 450: 893-898, 2007.
7. Network CGAR: Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068, 2008.
8. Bignell G, Greenman C, Davies H, et al: Signatures of mutation and selection in the cancer genome. Nature 463: 893-898, 2010.
9. Sato M, Takahashi K, Nagayama K, et al: Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer. Genes Chromosomes Cancer 44: 405-414, 2005.
10. Solomon D, Kim J, Cronin J, et al: Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma. Cancer Res 68: 10300-10306, 2008.
11. Veeriah S, Brennan C, Meng S, et al: The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancers. Proc Natl Acad Sci USA 106: 9435-9440, 2009.
12. Gonzalez-Brito M and Bixby J: Differential activities in adhesion and neurite growth of fibronectin type III repeats in the PTP-delta extracellular domain. Int J Dev Neurosci 24: 425-429, 2006.
13. Serra-Pagès C, Medley Q, Tang M, Hart A and Streuli M: Liprins, a family of LAR transmembrane protein-tyrosine phosphataseinteracting proteins. J Biol Chem 273: 15611-15620, 1998.
14. Woodings J, Sharp S and Machesky L: MIM-B, a putative metastasis suppressor protein, binds to actin and to protein tyrosine phosphatase delta. Biochem J 371: 463-471, 2003.
15. Gonzalez-Quevedo R, Shoffer M, Horng L and Oro A: Receptor tyrosine phosphatase-dependent cytoskeletal remodeling by the hedgehog-responsive gene MIM/BEG4. J Cell Biol 168: 453-463, 2005.
16. Ponta H, Sherman L and Herrlich P: CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4: 33-45, 2003.
17. Nakamura T, Hayashi T, Nasu-Nishimura Y, et al: PX-RICS mediates ER-to-Golgi transport of the N-cadherin/beta-catenin complex. Genes Dev 22: 1244-1256, 2008.
18. Kawasaki Y, Sato R and Akiyama T: Mutated APC and Asef are involved in the migration of colorectal tumour cells. Nat cell Biol 5: 211-215, 2003.
19. Jeanes A, Gottardi C and Yap A: Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 27: 6920-6929, 2008.
20. Wang J and Bixby J: Receptor tyrosine phosphatase-delta is a homophilic, neurite-promoting cell adhesion molecular for CNS neurons. Mol Cell Neurosci 14: 370-384, 1999.
21. Kawasaki Y, Sagara M, Shibata Y, Shirouzu M, Yokoyama S and Akiyama T: Identification and characterization of Asef2, a guanine-nucleotide exchange factor specific for Rac1 and Cdc42. Oncogene 26: 7620-7267, 2007.
22. Gilles C, Polette M, Mestdagt M, et al: Transactivation of vimentin by beta-catenin in human breast cancer cells. Cancer Res 63: 2658-2664, 2003.
23. Gavert N, Conacci-Sorrell M, Gast D, et al: L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 168: 633-642, 2005.
24. Vignjevic D, Schoumacher M, Gavert N, et al: Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer. Cancer Res 67: 6844-6853, 2007.
25. Morin P, Sparks A, Korinek V, et al: Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790, 1997.
26. Sparks A, Morin P, Vogelstein B and Kinzler K: Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58: 1130-1134, 1998.
27. Fodde R and Brabletz T: Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr Opin Cell Biol 19: 150-158, 2007.
28. Wielenga V, Smits R, Korinek V, et al: Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 154: 515-523, 1999.
29. Boon E, van der Neut R, van de Wetering M, Clevers H and Pals S: Wnt signaling regulates expression of the receptor tyrosine kinase met in colorectal cancer. Cancer Res 62: 5126-5128, 2002.
30. Al-Hajj M, Wicha M, Benito-Hernandez A, Morrison S and Clarke M: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988, 2003.
31. Du L, Wang H, He L, et al: CD44 is of functional importance for colorectal cancer stem cells. Clin Cancer Res 14: 6751-6760, 2008.
32. Van der Flier L, van Gijn M, Hatzis P, et al: Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell 136: 903-912, 2009.
33. Zheng H, Ying H, Wiedemeyer R, et al: PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas. Cancer Cell 17: 497-509, 2010.
34. O'Connell M and Weeraratna A: Hear the Wnt Ror: how melanoma cells adjust to changes in Wnt. Pigment Cell Melanoma Res 22: 724-739, 2009.
35. Müller T, Choidas A, Reichmann E and Ullrich A: Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration. J Biol Chem 274: 10173-10183, 1999.
36. Siu R, Fladd C and Rotin D: N-cadherin is an in vivo substrate for protein tyrosine phosphatase sigma (PTPsigma) and participates in PTPsigma-mediated inhibition of axon growth. Mol Cell Biol 27: 208-219, 2007.
37. Harder K, Moller N, Peacock J and Jirik F: Protein-tyrosine phosphatase alpha regulates Src family kinases and alters cellsubstratum adhesion. J Biol Chem 273: 31890-31900, 1998.
38. Zhu S, Bjorge J and Fujita D: PTP1B contributes to the oncogenic properties of colon cancer cells through Src activation. Cancer Res 67: 10129-10137, 2007.